Oncology Care Model Has Positive Effect on Supportive Care Medication Use, Cost
An analysis of supportive care medication use demonstrated the effect the oncology care model has on use and costs of these medications in patients with cancer.
An analysis of supportive care medication use demonstrated the effect the oncology care model has on use and costs of these medications in patients with cancer.
A presentation at the ONA Summit reviewed the cancer screening guidelines from the ACS and USPSTF.
There was no significant difference in post-infusion hospitalizations between patients with and without a history of cancer.
The highest rate of non-concordant care was seen in patients with cervical cancer.
Of the patients studied, 59% demonstrated poor prognostic understanding of curability.
Compared with patients who had a medium platelet count, patients with a very high platelet count had more than double the risk of a solid tumor diagnosis.
Researchers sought to determine whether patients with cancer who were hospitalized with COVID-19 would have a higher mortality rate.
The study showed differences by cancer type and race/ethnicity.